Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Boyer

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
Plos One|September 17, 2013
Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based systemPhilip Wing-Lok Ho, Zero Ho-Man Tse, Hui-Fang Liu, et al.
Ophthalmology Science|November 28, 2024
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone PreservationJustis P Ehlers, Allen Hu, David Boyer, et al.
Ophthalmology|March 24, 2012
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyDavid Boyer, Jeffrey Heier, David M Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2020
Intrinsic electronic conductivity of individual atomically resolved amyloid crystals reveals micrometer-long hole hopping via tyrosinesCatharine Shipps, H Ray Kelly, Peter J Dahl, et al.
Ophthalmology|October 7, 2016
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudyYasir J Sepah, Mohammad Ali Sadiq, David Boyer, et al.
Ophthalmology|June 7, 2011
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingJeffrey S Heier, David Boyer, Quan Dong Nguyen, et al.
Ophthalmology|February 3, 2012
Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC StudyDiana V Do, Emily W Gower, Sandra D Cassard, et al.
Diagnostics (Basel, Switzerland)|October 29, 2025
Deep Learning-Based Segmentation of Geographic Atrophy: A Multi-Center, Multi-Device Validation in a Real-World Clinical CohortHasenin Al-Khersan, Simrat K Sodhi, Jessica A Cao, et al.
Journal of Neuroscience Research|June 11, 2005
Methyl-4-phenylpyridinium ion modulates expression of mitochondrial uncoupling proteins 2, 4, and 5 in catecholaminergic (SK-N-SH) cellsPhilip Wing-Lok Ho, David Yiu-Leung Chan, Ken Hon-Hung Kwok, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
Plos One|September 17, 2013
Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based systemPhilip Wing-Lok Ho, Zero Ho-Man Tse, Hui-Fang Liu, et al.
Ophthalmology Science|November 28, 2024
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone PreservationJustis P Ehlers, Allen Hu, David Boyer, et al.
Ophthalmology|March 24, 2012
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyDavid Boyer, Jeffrey Heier, David M Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2020
Intrinsic electronic conductivity of individual atomically resolved amyloid crystals reveals micrometer-long hole hopping via tyrosinesCatharine Shipps, H Ray Kelly, Peter J Dahl, et al.
Ophthalmology|October 7, 2016
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudyYasir J Sepah, Mohammad Ali Sadiq, David Boyer, et al.
Ophthalmology|June 7, 2011
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingJeffrey S Heier, David Boyer, Quan Dong Nguyen, et al.
Ophthalmology|February 3, 2012
Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC StudyDiana V Do, Emily W Gower, Sandra D Cassard, et al.
Diagnostics (Basel, Switzerland)|October 29, 2025
Deep Learning-Based Segmentation of Geographic Atrophy: A Multi-Center, Multi-Device Validation in a Real-World Clinical CohortHasenin Al-Khersan, Simrat K Sodhi, Jessica A Cao, et al.
Journal of Neuroscience Research|June 11, 2005
Methyl-4-phenylpyridinium ion modulates expression of mitochondrial uncoupling proteins 2, 4, and 5 in catecholaminergic (SK-N-SH) cellsPhilip Wing-Lok Ho, David Yiu-Leung Chan, Ken Hon-Hung Kwok, et al.
Pageof 8